AlphaCrest Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,268	Closed	-$280K	–	120
2022 Q3	$280K	Buy	+6,268	New	+$280K	0.02%	1161
2020 Q2	–	Sell	-3,800	Closed	-$224K	–	903
2020 Q1	$224K	Buy	+3,800	New	+$224K	0.03%	907